Aehr Test Systems, Inc.
AEHR
$12.46
-$0.48-3.71%
| Weiss Ratings | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | B | |||
| Rating Factors | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Excellent | |||
| Efficiency Index | Excellent | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 2.48 | |||
| Price History | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -7.84% | |||
| 30-Day Total Return | -16.99% | |||
| 60-Day Total Return | 15.37% | |||
| 90-Day Total Return | 10.76% | |||
| Year to Date Total Return | -50.06% | |||
| 1-Year Total Return | -74.65% | |||
| 2-Year Total Return | -16.21% | |||
| 3-Year Total Return | 12.15% | |||
| 5-Year Total Return | 802.90% | |||
| 52-Week High % Change | -75.61% | |||
| 52-Week Low % Change | 26.75% | |||
| Price | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $51.08 | |||
| 52-Week Low Price | $9.83 | |||
| 52-Week Low Price (Date) | Jun 26, 2024 | |||
| 52-Week High Price (Date) | Sep 18, 2023 | |||
| Valuation | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 368.61M | |||
| Enterprise Value | 325.65M | |||
| Price/Earnings (TTM) | 11.10 | |||
| Earnings Per Share (TTM) | 1.12 | |||
| Earnings Per Share Growth | 125.10% | |||
| Price/Earnings To Growth | 0.09 | |||
| Price/Sales (TTM) | 5.54 | |||
| Price/Book (Q) | 3.24 | |||
| Enterprise Value/Revenue (TTM) | 4.92 | |||
| Price | $12.46 | |||
| Enterprise Value/EBITDA (TTM) | 30.34 | |||
| Enterprise Value/EBIT | 32.31 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 29.46M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 510-623-9400 | |||
| Address | 400 Kato Terrace Fremont, CA 94539 | |||
| Website | www.aehr.com | |||
| Country | United States | |||
| Year Founded | 1977 | |||
| Profitability | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 15.21% | |||
| Profit Margin | 50.07% | |||
| Management Effectiveness | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 5.57% | |||
| Return on Equity | 35.42% | |||
| Income Statement | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 66.22M | |||
| Total Revenue (TTM) | 66.22M | |||
| Revenue Per Share | $2.25 | |||
| Gross Profit (TTM) | 32.54M | |||
| EBITDA (TTM) | 10.74M | |||
| EBIT (TTM) | 10.08M | |||
| Net Income (TTM) | 33.16M | |||
| Net Income Avl. to Common (TTM) | 33.16M | |||
| Total Revenue Growth (Q YOY) | -25.46% | |||
| Earnings Growth (Q YOY) | 290.51% | |||
| EPS Diluted (TTM) | 1.12 | |||
| EPS Diluted Growth (Q YOY) | 289.75% | |||
| Balance Sheet | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 49.16M | |||
| Cash Per Share (Q) | $1.67 | |||
| Total Current Assets (Q) | 97.85M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 111.59M | |||
| Current Ratio (Q) | 9.312 | |||
| Book Value Per Share (Q) | $3.85 | |||
| Total Assets (Q) | 127.91M | |||
| Total Current Liabilities (Q) | 10.51M | |||
| Total Debt (Q) | 6.20M | |||
| Total Liabilities (Q) | 16.32M | |||
| Total Common Equity (Q) | 111.59M | |||
| Cash Flow | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 17.25M | |||
| Cash from Financing (TTM) | 139.00K | |||
| Net Change in Cash (TTM) | 19.11M | |||
| Levered Free Cash Flow (TTM) | -4.26M | |||
| Cash from Operations (TTM) | 1.76M | |||
